Clinical trial Recruiting at 1 site Observational Ages 80 and up

A cohort of healthy elderly individuals aged 80 and older

Official title: The Healthy Elderly Longevity Cohort

Run by Scripps Translational Science Institute · NCT01004133 · Data updated 2026-11-12

This study looks at healthy older adults aged 80 and up to see how their genes affect their health as they age.

More Healthy Aging trials

Quick facts

Study typeObservational
Ages80 Years and up
SexAll
Enrollment5000 (estimated)
SponsorScripps Translational Science Institute
Academic / other
Drugs / interventionsdoxorubicin
Locations1 site (La Jolla, California)
StatusRecruiting
StartedAugust 2007
Main results expectedJanuary 2030
Study endsJanuary 2030
Registry record updatedJanuary 17, 2025
Trial IDNCT01004133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 80 years or older who are generally healthy or have mild medical conditions associated with aging.

Probably not a fit

Patients under 80 years old or those with significant chronic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on individuals aged 80 and older who are generally healthy or have mild age-related medical conditions. It aims to explore the interplay between genetics and health in the elderly population, leveraging advancements from the human genome project to identify genetic variants associated with health phenotypes. Participants will undergo blood or saliva collection to facilitate genetic analysis. The study seeks to enhance understanding of how genetic factors contribute to maintaining health in older adults.

Why it matters

Potential benefit: If successful, this study could provide insights into the genetic factors that promote healthy aging, potentially leading to improved health strategies for the elderly.

How similar studies have gone: While this study explores a relatively novel approach to understanding health in the elderly, similar studies have shown promise in identifying genetic factors related to aging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 80 years or older
2. Eligible for blood draw and/or saliva collection
3. Be reliable, cooperative and willing to comply with all protocol-specified procedures
4. Able to understand and grant informed consent
5. Be healthy or have mild medical conditions that may be associated with the normal aging process, including:

   * Hypertension, well controlled (no more than 3 medications)
   * Osteoporosis, Osteopenia and/or osteoarthritis
   * Benign prostatic hypertrophy
   * Cataracts, Glaucoma, Macular Degeneration
   * Dyslipidemia
   * Hypothyroidism
   * Pre-diabetes/impaired fasting glucose (fasting blood glucose 100-126 mg/dL, if known)

Exclusion Criteria:

1. \< 80 years old
2. Participants have been previously enrolled in The Scripps Genebank Healthy Elderly Cohort
3. Treatment with any investigational agents or devices within thirty days preceding enrollment in the study.
4. Self-reported history or current diagnosis of significant chronic conditions including:

   * Any Cancer (including polycythemia; excluding basal or squamous cell skin cancer).
   * Coronary Artery Disease/Myocardial Infarction
   * Stroke/TIA
   * Deep Vein Thrombosis/Pulmonary Embolus
   * Chronic Renal Disease/Hemodialysis
   * Significant Auto-immune/Inflammatory conditions such as (Rheumatoid Arthritis, Lupus, Crohn's, etc.
   * Alzheimer's/Parkinson's
   * Diabetes (Hemoglobin A1C \> 6.5 % or fasting glucose \>126 mg/dL or treated with oral diabetic medication or insulin if known)
   * Aortic or Cerebral Aneurysm
5. Currently taking any of the following medications on a regular basis:

   * Oral chemotherapeutic agents (ex.: tamoxifen, doxorubicin, mitoxantrone, bleomycin)
   * Anti-platelet agents, not including aspirin (ex.: clopidogrel/plavix, dipyridamole/aggrenox/persantine, ticlopidine/ticlid)
   * Cholinesterase inhibitor for Alzheimer's disease (i.e. donepezil/Aricept)
   * Insulin
6. Subject has a significant medical condition which, in the Investigator's opinion, may interfere with the patient's optimal participation in the study or would potentially confound interpretation of the individual's phenotype.

Where it's running

  • Scripps Translational Science Institute
    La Jolla, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.